623 related articles for article (PubMed ID: 9845266)
1. Melanocortins and cardiovascular regulation.
Versteeg DH; Van Bergen P; Adan RA; De Wildt DJ
Eur J Pharmacol; 1998 Oct; 360(1):1-14. PubMed ID: 9845266
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity analysis for the effects of gamma-MSH/ACTH-like peptides on cerebral hemodynamics in rats.
Van Bergen P; Van Der Vaart JG; Kasbergen CM; Versteeg DH; De Wildt DJ
Eur J Pharmacol; 1996 Dec; 318(2-3):357-68. PubMed ID: 9016926
[TBL] [Abstract][Full Text] [Related]
3. Cyclic lactam alpha-melanotropin analogues of Ac-Nle4-cyclo[Asp5, D-Phe7,Lys10] alpha-melanocyte-stimulating hormone-(4-10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors.
Hruby VJ; Lu D; Sharma SD; Castrucci AL; Kesterson RA; al-Obeidi FA; Hadley ME; Cone RD
J Med Chem; 1995 Sep; 38(18):3454-61. PubMed ID: 7658432
[TBL] [Abstract][Full Text] [Related]
4. Further evidence that melanocortins prevent myocardial reperfusion injury by activating melanocortin MC3 receptors.
Mioni C; Giuliani D; Cainazzo MM; Leone S; Bazzani C; Grieco P; Novellino E; Tomasi A; Bertolini A; Guarini S
Eur J Pharmacol; 2003 Sep; 477(3):227-34. PubMed ID: 14522361
[TBL] [Abstract][Full Text] [Related]
5. Different cardiovascular profiles of three melanocortins in conscious rats; evidence for antagonism between gamma 2-MSH and ACTH-(1-24).
Van Bergen P; Kleijne JA; De Wildt DJ; Versteeg DH
Br J Pharmacol; 1997 Apr; 120(8):1561-7. PubMed ID: 9113379
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular effects of gamma-MSH/ACTH-like peptides: structure-activity relationship.
Van Bergen P; Janssen PM; Hoogerhout P; De Wildt DJ; Versteeg DH
Eur J Pharmacol; 1995 Dec; 294(2-3):795-803. PubMed ID: 8750747
[TBL] [Abstract][Full Text] [Related]
7. Receptor biology of the melanocortins, a family of neuroimmunomodulatory peptides.
Tatro JB
Neuroimmunomodulation; 1996; 3(5):259-84. PubMed ID: 9218248
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of melanocortin peptides on neural melanocortin receptors.
Adan RA; Cone RD; Burbach JP; Gispen WH
Mol Pharmacol; 1994 Dec; 46(6):1182-90. PubMed ID: 7808440
[TBL] [Abstract][Full Text] [Related]
9. Asp10 in Lys-gamma2-MSH determines selective activation of the melanocortin MC3 receptor.
Oosterom J; Burbach JP; Gispen WH; Adan RA
Eur J Pharmacol; 1998 Jul; 354(1):R9-11. PubMed ID: 9726642
[TBL] [Abstract][Full Text] [Related]
10. A study on possible modulating and direct effects of gamma2-MSH and ACTH-(1-24) on the cardiovascular system of the rat.
Van Bergen P; Vleeming W; Van Heijst BG; Versteeg DH; De Wildt DJ
Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):220-9. PubMed ID: 9750008
[TBL] [Abstract][Full Text] [Related]
11. Melanocortin antagonists define two distinct pathways of cardiovascular control by alpha- and gamma-melanocyte-stimulating hormones.
Li SJ; Varga K; Archer P; Hruby VJ; Sharma SD; Kesterson RA; Cone RD; Kunos G
J Neurosci; 1996 Aug; 16(16):5182-8. PubMed ID: 8756446
[TBL] [Abstract][Full Text] [Related]
12. Molecular cloning, functional expression and pharmacological characterization of a mouse melanocortin receptor gene.
Desarnaud F; Labbe O; Eggerickx D; Vassart G; Parmentier M
Biochem J; 1994 Apr; 299 ( Pt 2)(Pt 2):367-73. PubMed ID: 8172596
[TBL] [Abstract][Full Text] [Related]
13. Identification of antagonists for melanocortin MC3, MC4 and MC5 receptors.
Adan RA; Oosterom J; Ludvigsdottir G; Brakkee JH; Burbach JP; Gispen WH
Eur J Pharmacol; 1994 Nov; 269(3):331-7. PubMed ID: 7895772
[TBL] [Abstract][Full Text] [Related]
14. Relevance of the C-terminal Arg-Phe sequence in gamma(2)-melanocyte-stimulating hormone (gamma(2)-MSH) for inducing cardiovascular effects in conscious rats.
Nijsen MJ; de Ruiter GJ; Kasbergen CM; Hoogerhout P; de Wildt DJ
Br J Pharmacol; 2000 Dec; 131(7):1468-74. PubMed ID: 11090122
[TBL] [Abstract][Full Text] [Related]
15. Characterization of melanocortin receptor ligands on cloned brain melanocortin receptors and on grooming behavior in the rat.
Adan RA; Szklarczyk AW; Oosterom J; Brakkee JH; Nijenhuis WA; Schaaper WM; Meloen RH; Gispen WH
Eur J Pharmacol; 1999 Aug; 378(3):249-58. PubMed ID: 10493100
[TBL] [Abstract][Full Text] [Related]
16. Accelerating sensory recovery after sciatic nerve crush: non-selective versus melanocortin MC4 receptor-selective peptides.
Nijenhuis WA; Wanders N; Kruijtzer JA; Liskamp RM; Gispen WH; Adan RA
Eur J Pharmacol; 2004 Jul; 495(2-3):145-52. PubMed ID: 15249163
[TBL] [Abstract][Full Text] [Related]
17. Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors.
Haskell-Luevano C; Nikiforovich G; Sharma SD; Yang YK; Dickinson C; Hruby VJ; Gantz I
J Med Chem; 1997 May; 40(11):1738-48. PubMed ID: 9171884
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of brain melanocortin receptors suggested by differential ligand binding in situ.
Tatro JB; Entwistle ML
Brain Res; 1994 Jan; 635(1-2):148-58. PubMed ID: 8173950
[TBL] [Abstract][Full Text] [Related]
19. ACTH-(4-10) through gamma-MSH: evidence for a new class of central autonomic nervous system-regulating peptides.
Gruber KA; Callahan MF
Am J Physiol; 1989 Oct; 257(4 Pt 2):R681-94. PubMed ID: 2552843
[TBL] [Abstract][Full Text] [Related]
20. Conformation of the core sequence in melanocortin peptides directs selectivity for the melanocortin MC3 and MC4 receptors.
Oosterom J; Nijenhuis WA; Schaaper WM; Slootstra J; Meloen RH; Gispen WH; Burbach JP; Adan RA
J Biol Chem; 1999 Jun; 274(24):16853-60. PubMed ID: 10358030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
